Open AccessRecommended Guidelines for Use of Intravitreal Aflibercept With a Treat-and-Extend Regimen for the Management of Neovascular Age-Related Macular Degeneration in the Asia-Pacific Region: Report From a Consensus Panel
Author(s) -
Adrian Koh,
Paolo Lanzetta,
Won Ki Lee,
ChiChun Lai,
WaiMan Chan,
Chung–May Yang,
Chui Ming Gemmy Cheung
Publication year - 2017
Publication title -
asia-pacific journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.163
H-Index - 20
ISSN - 2162-0989
DOI - 10.22608/apo.2016125
Subject(s) - aflibercept , macular degeneration , medicine , regimen , disease , blindness , bevacizumab , intensive care medicine , optometry , ophthalmology , surgery , chemotherapy
To summarize recommendations for the use of intravitreal aflibercept with a treat-and-extend regimen to manage neovascular age-related macular degeneration (nAMD) in the Asia-Pacific region. Although anti-vascular endothelial growth factor therapies have improved the quality of life of patients with nAMD, a leading cause of blindness and visual impairment, the high treatment frequency recommended by current guidelines places a significant burden on patients and healthcare providers.